Originated from an enthusiastic group of technocrats from world renowned UDCT (now ICT, Mumbai) with a collective demonstrated global experience of over 100 years in the fields of Organic Synthesis, Chemical Engineering & Techno- Marketing, aSai Vishwa is now a venture in building stage. With a prime focus on the technology innovations, dedication to safety, quality and environment, aSai Vishwa thrives to be a cost effective alternative to the plethora of compromised organizations. aSai Vishwa has laid out aggressive plans to become a leading manufacturer of Advanced Intermediates and Active Pharmaceutical Ingredients, trusted choice for CMRO, reliable formulation company and renowned name in generics in near term future. A strong regulatory compliance backed up by the confidentiality and intellectual property preservation will be at the forefront of aSai Vishwa’s success attributes.

Currently, The Intermediates and APIs for various therapeutic categories are being developed and scaled-up to commercial scale by aSai. aSai also undertakes Contract Manufacturing/ Custom Synthesis Projects of domestic as well as abroad customers with a strong emphasis on Quality, Reliability and Cost Effectiveness

Following Therapeutic Categories are being catered by aSai

  • Cardiovascular
  • Cancer
  • Diabetic
  • Glaucoma
  • Hypertension
  • Respiratory

The infrastructure being set-up at aSai Vishwa for manufacturing of Advanced Intermediates and andIntermediatesis one of the Finest designed to meet the International Standards and cGMPscatering to the ever increasing requirements of the domestic and global pharmaceutical market.aSai Vishwa is inducting scientific talent across various functions spanning from organic & analytical chemistry, process safety and chemical engineering, regulatory compliance and documentation and intellectual property management. The planned Leading Technology Cell (LTC) will support the aforementioned capability. The LTC will be made up of a highly skilled team of process chemical engineers and chemists who work with the finest technology and with the process and analytical chemists to ensure quality of not only the final product but at all stages of process development cycle.

LTC will host following key technology Platforms:

  • Chiral Synthesis Technology (CST)
  • Regioselective Synthesis Technology (RST)
  • Stereoselective Synthesis Technology (SST)
  • Reaction Engineering Technology (RET)
  • Novel Crystallization Technology (NCT)
  • Continuous, spherulitic, instantaneous precipitations, etc
  • Hazardous Reactions Technology (HRT)
  • Microreactors for highly exothermic reactions, etc.
  • Continuous Process Technology (CPT)
  • High Pressure/Temperature Process Technology (HPT)
  • Hydrogenations, etc.
  • Peptide Synthesis Technology (PST)